Delaying surgery beyond six weeks after systemic therapy reduces postoperative morbidity without evidence of impaired oncologic outcomes in colorectal liver metastases - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Postponing Surgery Beyond Six Weeks After Systemic Treatment Lowers Postoperative Complications Without Compromising Oncological Outcomes in Colorectal Liver Metastases

  • By

  • Esther Giehl-Brown

  • Rajan Nikbakhsh

  • Ana Mansourkiaei

  • Laila Jötten

  • Bruno Christian Köhler

  • Thomas Longerich

  • Bo Kong

  • Arianeb Mehrabi

  • Markus W Büchler

  • Mohammed Al-Saeedi

  • Christoph Kahlert

  • June 30, 2026

Share

  • 1

    Colorectal liver metastases (CRLM) occur in up to 20% of colorectal cancer patients at diagnosis, with surgical resection being the only curative option.

  • 2

    Neoadjuvant systemic therapy (NAT) can downstage initially unresectable CRLM, but its role in resectable cases remains controversial.

  • 3

    Optimal timing of surgery after NAT, known as time-to-surgery (TTS), may influence postoperative morbidity and long-term outcomes.

  • 4

    A retrospective analysis of 159 patients evaluated the impact of TTS on postoperative complications and oncological outcomes after surgery for CRLM.

  • 5

    The study aims to clarify the relationship between surgical timing and postoperative morbidity to inform perioperative decision-making.

Original Source(s)

Related Content